Roche announced the retirement of Hans Clevers, Head of Roche Pharma Research and Early Development, effective August 2025. Clevers, a renowned scientist, significantly contributed to advancing Roche's drug development. His leadership accelerated several promising medicines into late-stage development. Roche also announced the retirement of Barbara Schädler, Head of Group Communications, at the end of the year. Schädler modernized Roche's communication strategies during her tenure. Her leadership was particularly impactful during the COVID-19 pandemic. Roche will announce their successors shortly. Roche is the world's largest biotechnology company and a leader in in-vitro diagnostics. The company emphasizes personalized healthcare and sustainability. Roche is committed to achieving net-zero emissions by 2045. Genentech and Chugai Pharmaceutical are part of the Roche Group.